Archive

February 25, 2026

Browsing

Eagle Energy Metals Corp. (“Eagle”), a next-generation nuclear energy company with rights to the largest conventional, measured and indicated uranium deposit in the United States, today announced that it has completed its business combination with Spring Valley Acquisition Corp. II (OTC: SVIIF) (“SVII”), a special purpose acquisition company (the “Business Combination”). The Business Combination was approved by SVII shareholders in a special meeting held on February 23, 2026 and formally closed on February 24, 2026.

The new combined company will operate as “Eagle Nuclear Energy Corp.” (“Eagle Nuclear”). On February 25, 2026, Eagle Nuclear’s common stock and public warrants will begin trading on the Nasdaq under the ticker symbols “NUCL” and “NUCLW”, respectively.

Mark Mukhija, Eagle’s CEO, commented: “The completion of our business combination with SVII is the culmination of months of hard work and company development. The closing of this transaction marks another key milestone in our efforts to rebuild a secure domestic nuclear supply chain here in the United States. Anchored by our significant uranium deposit and SMR technology, we believe we are well positioned to restore American leadership in the nuclear industry at a time when AI, quantum computing, and cryptocurrency are driving unprecedented electricity demand. We are optimistic about the path ahead and look forward to addressing electricity demand and uranium market needs moving forward.”

Chris Sorrells, Chairman & CEO of SVII, added: “Today’s successful merger completion marks a significant milestone for our company, our shareholders and the future of the U.S. nuclear industry. Eagle is a unique partner, with significant domestic uranium capabilities that can directly respond to market demand, alongside record private investments in U.S. nuclear projects. We look forward to working closely with the Eagle team as they continue to address the need for domestic uranium production.”

Advisors

Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, is the exclusive financial advisor, lead capital markets advisor and private placement agent to SVII. Greenberg Traurig, LLP is serving as legal counsel to SVII, and Nelson Mullins Riley & Scarborough LLP is serving as legal counsel to Eagle. Gateway Group is serving as investor relations and public relations advisor for the transaction.

About Eagle Energy Metals Corp.

Eagle Energy Metals Corp. is a next-generation nuclear energy company that combines domestic uranium exploration with proprietary Small Modular Reactor (SMR) technology. The Company holds the rights to the largest conventional, measured and indicated uranium deposit in the United States, located in southeastern Oregon. This includes the Aurora deposit, with 32.75Mlbs Indicated and 4.98Mlbs Inferred (SK-1300 TRS) of near-surface uranium resource, and the adjacent Cordex deposit, which offers significant potential to expand the project’s overall resource inventory. By integrating advanced SMR technology with a sizeable uranium asset, Eagle is building an integrated nuclear platform positioned to help restore American leadership in the global nuclear industry.

For more information about Eagle Energy Metals Corp., visit www.eagleenergymetals.com.

About Spring Valley Acquisition Corp. II

Spring Valley Acquisition Corp. II (“Spring Valley II”) is part of a family of investment vehicles formed for the purpose of acquiring or merging with a business focused on the Power Infrastructure and Decarbonization sectors. Over the past five years, Spring Valley has raised $920 million across four IPOs. Spring Valley II is led by Christopher D. Sorrells, Chief Executive Officer and Chairman, and Robert Kaplan, Chief Financial Officer and Head of Business Development. Spring Valley I successfully completed its business combination with NuScale Power (NYSE: SMR), a leading U.S. small modular reactor (“SMR”) technology company, and Spring Valley II successfully completed its business combination with Eagle Energy Metals, a next-generation nuclear energy company that combines domestic uranium exploration with proprietary SMR technology. Spring Valley III has announced a business combination with General Fusion, a global leader in fusion energy developing a differentiated, engineering-driven approach to commercial fusion power.

SVII maintains a corporate website at https://sv-ac.com.

Cautionary Note Regarding Forward-Looking Statements

Certain statements included in this press release are not historical facts but are forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. Any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are also forward-looking statements. In some cases, you can identify forward-looking statements by words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “strategy,” “future,” “opportunity,” “may,” “target,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” “preliminary,” or similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements include, without limitation, SVII’s, Eagle Nuclear’s, Eagle’s, or their respective management teams’ expectations concerning the Business Combination and expected benefits thereof; the outlook for Eagle’s or Eagle Nuclear’s business; the abilities to execute Eagle’s or Eagle Nuclear’s strategies; projected and estimated financial performance; anticipated industry trends; the future price of minerals; future capital expenditures; success of exploration activities; mining or processing issues; government regulation of mining operations; and environmental risks; as well as any information concerning possible or assumed future results of operations of Eagle or Eagle Nuclear. The forward-looking statements are based on the current expectations of the respective management teams of Eagle, Eagle Nuclear, and SVII, as applicable, and are inherently subject to uncertainties and changes in circumstance and their potential effects. There can be no assurance that future developments will be those that have been anticipated. These forward-looking statements involve a number of risks, uncertainties or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, (i) market risks; (ii) the effect of the Business Combination on Eagle’s business relationships, performance, and business generally; (iii) risks that the Business Combination disrupts current plans of Eagle and potential difficulties in its employee retention as a result of the Business Combination; (iv) the outcome of any legal proceedings that may be instituted against Eagle or SVII related to the Business Combination; (v) failure to realize the anticipated benefits of the Business Combination; (vi) the inability to maintain the listing of Eagle Nuclear’s securities on Nasdaq Capital Market or a comparable exchange; (vii) the risk that the price of Eagle Nuclear’s securities may be volatile due to a variety of factors, including changes in laws, regulations, technologies, natural disasters or health epidemics/pandemics, national security tensions, and macro- economic and social environments affecting its business; (viii) fluctuations in spot and forward markets for lithium and uranium and certain other commodities (such as natural gas, fuel oil and electricity); (ix) restrictions on mining in the jurisdictions in which Eagle operates; (x) laws and regulations governing Eagle’s operation, exploration and development activities, and changes in such laws and regulations; (xi) Eagle’s ability to obtain or renew the licenses and permits necessary for the operation and expansion of its existing operations and for the development, construction and commencement of new operations; (xii) risks and hazards associated with the business of mineral exploration, development and mining (including environmental hazards, potential unintended releases of contaminants, industrial accidents, unusual or unexpected geological or structural formations, pressures, cave-ins and flooding); (xiii) inherent risks associated with tailings facilities and heap leach operations, including failure or leakages; the speculative nature of mineral exploration and development; the inability to determine, with certainty, production and cost estimates; inadequate or unreliable infrastructure (such as roads, bridges, power sources and water supplies); (xiv) environmental regulations and legislation; (xv) the effects of climate change, extreme weather events, water scarcity, and seismic events, and the effectiveness of strategies to deal with these issues; (xvi) risks relating to Eagle’s exploration operations; (xvii) fluctuations in currency markets; (xviii) the volatility of the metals markets, and its potential to impact Eagle’s ability to meet its financial obligations; (xix) disputes as to the validity of mining or exploration titles or claims or rights, which constitute most of Eagle’s property holdings; (xx) Eagle’s ability to complete and successfully integrate acquisitions; (xxi) increased competition in the mining industry for properties and equipment; (xxii) limited supply of materials and supply chain disruptions; (xxiii) relations with and claims by indigenous populations; (xxiv) relations with and claims by local communities and non-governmental organizations; and (xxv) the risk that other capital needed by Eagle Nuclear may not be raised on favorable terms, or at all. The foregoing list is not exhaustive, and there may be additional risks that neither SVII, Eagle, nor Eagle Nuclear presently know or that SVII, Eagle, and Eagle Nuclear currently believe are immaterial. You should carefully consider the foregoing factors, any other factors discussed in this press release and the other risks and uncertainties described in the “Risk Factors” section of the Form 10-K filed by SVII for the year ended December 31, 2024, the risks described in the registration statement on Form S-4 initially filed by Eagle Nuclear on September 30, 2025, and the definitive proxy statement / prospectus contained therein, and any amendments or supplements thereto, and those discussed and identified in other filings made with the SEC by SVII, Eagle Nuclear or Eagle from time to time, which may be found on the SEC’s website at www.sec.gov. Eagle, Eagle Nuclear, and SVII caution you against placing undue reliance on forward-looking statements, which reflect current beliefs and are based on information currently available as of the date a forward-looking statement is made. Forward-looking statements set forth in this press release speak only as of the date of this press release. Neither Eagle, SVII, nor Eagle Nuclear undertakes any obligation to revise forward-looking statements to reflect future events, changes in circumstances, or changes in beliefs. In the event that any forward-looking statement is updated, no inference should be made that Eagle Nuclear, Eagle or SVII will make additional updates with respect to that statement, related matters, or any other forward-looking statements.

Investor Relations Contact:

775-335-2029
info@eagleenergymetals.com

Media Relations Contact:

Gateway Group
Zach Kadletz, Brenlyn Motlagh
949-574-3860
EAGLE@Gateway-grp.com

Source

This post appeared first on investingnews.com

Faraday Copper (TSX:FDY,OTCQX:CPPKF) has signed a letter of intent (LOI) to acquire BHP’s (ASX:BHP,NYSE:BHP,LSE:BHP) San Manuel property, which sits next to its Copper Creek project in Arizona.

The company says the move will combine the two adjacent assets into a single US-focused copper district.

San Manuel includes the legacy San Manuel and Kalamazoo deposits, the former plant site, closed tailings facilities and surrounding BHP-owned land, along with related mineral rights, quarries and associated assets.

The mine operated between 1955 and 1999 as one of the largest underground copper mines in the US, producing more than 4.5 million metric tons of copper. Faraday will assume all environmental and closure liabilities tied to the property.

Copper Creek, which is located roughly 80 road kilometers northeast of Tucson and about 19 kilometers from San Manuel, is a porphyry copper project that is 100 percent owned by Faraday.

The firm released an updated resource estimate and a preliminary economic assessment in 2023.

The deposit remains open in all directions and hosts both breccia-hosted and vein-style mineralization. Faraday says significant exploration upside remains, with less than 15 percent of known breccia occurrences drill tested.

The proposed consolidation would add approximately 27,000 acres of private land and access to existing regional infrastructure. Faraday has also outlined a staged development concept prioritizing copper cathode production, followed by open-pit sulfides and later underground operations.

If completed, the transaction would see Faraday issue common shares to BHP equivalent to a 30 percent interest in the company on a fully diluted basis at closing.

BHP would also receive customary investor rights so long as it maintains a minimum shareholding.

“This agreement provides the opportunity for a transformative acquisition as it looks to consolidate two adjacent and complementary assets in the heart of the Arizona copper corridor at a time when sourcing of critical minerals within the USA is essential,” Faraday President and CEO Paul Harbidge said in a release.

“The combined project has the potential to become a multi-generational copper district delivering made-in-America copper, while providing significant economic opportunities to the local communities.”

For BHP, the deal would convert a legacy asset into a strategic equity position in a junior developer focused on US copper at a time when market participants are increasingly calling for a supply crunch.

The LOI includes a six month exclusivity period and a financing participation clause under which BHP has agreed to subscribe for 30 percent of any Faraday equity raise over the next 24 months, up to US$20 million.

Separately, Faraday recently announced a non-brokered private placement of up to C$100 million priced at C$4.20 per share. Strategic investors, including the Lundin Family Trusts and BHP, intend to participate.

The proceeds are earmarked primarily for advancing copper projects in Pinal County, including expenses related to the planned San Manuel acquisition.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Germany’s medical cannabis market exploded in 2025, with prescriptions surging 3,300 percent from March 2024 to December 2025, per Bloomwell Group’s Cannabis Barometer.

That’s according to Niklas Kouparanis and Dr. Julian Wichmann, co-founders of the Bloomwell Group, a Frankfurt-based cannabis company that operates Germany’s largest digital platform for medical cannabis.

According to the report’s authors, this environment is setting the stage for Germany’s medical cannabis market to quickly become one of the largest in Europe.

Reform fuels cannabis growth in Germany

Bloomwell’s review, built on anonymized real-world data from hundreds of thousands of self-paying patient prescriptions filled via its app, e-prescriptions and partner pharmacies from January 2024 to December 2025, shows Germany’s medical cannabis market saw a 3,300 percent surge in prescriptions by December 2025 compared with March 2024, the final month before medical cannabis was reclassified and removed from the country’s list of narcotics.

“What we’re seeing is a fundamental shift in patient access to legally prescribed, medically supervised and digitally accessible cannabis following regulatory reform,” said Kouparanis.

The country’s Cannabis Act (CanG) removed cannabis from its Narcotics Act (BtMG) and enacted the Medical Cannabis Act (MedCanG), shifting prescriptions from strict narcotic controls to standard pharmaceutical processes. The act enabled telemedicine and easier approvals to boost access for chronic conditions.

Prescriptions hit record highs in late 2025, reflecting telemedicine’s role in transitioning self-medicating patients to regulated care; however, misuse debates erupted that same year, with the Federal Ministry of Health drafting amendments driven by Minister of Health Nina Warken’s concerns over a 400 percent import surge, which she cited as evidence of potential abuse via telemedicine platforms.

In October 2025, the German Cabinet formally approved a draft of the amendment, which banned new remote prescriptions and mail-order sales. The draft was submitted to the European Union’s Technical Regulations Information System for review, with the first Bundestag reading occurring on December 18, 2025. As of February 2026, the parliamentary process is ongoing; second and third readings are targeted for this spring.

Amid these headwinds, Kouparanis emphasized resilience.

“In the face of political uncertainty and proposed regulatory pushback, the biggest achievement for Germany’s medical cannabis industry is that we’ve continued to guarantee a secure and stable supply of prescriptions for more than a million medical cannabis patients,” he said. “Imports are breaking records, and medical cannabis has firmly established itself as part of mainstream healthcare.”

German cannabis market trends

The report identifies several growth trends in the German medical cannabis market, including an increase in products — while fewer than 470 strains were available at the start of 2025, by the fourth quarter there were 720.

At the same time, patient preferences for specific flower attributes have shifted.

Patients increasingly favor non-irradiated flowers, which captured roughly 90 percent of the market share from July to December 2025, reflecting demand for natural products.

“Despite this rise in demand, Germany’s supply of medical cannabis has remained stable and more affordable. We’ve found that the average price per gram of medical cannabis flower fell by more than 3 euros over the course of 2025, declining from 8.33 euros in January to 5.23 euros in December,’ commented Kouparanis.

‘These developments show that the market is successful, competitive, resilient and continues to deliver safe and reliable medical cannabis to patients in need,’ the expert added.

According to the report, telemedicine and mail-order pharmacy efficiencies can save health insurers 2.9 billion euros annually versus in-person care, while cannabis therapy cuts sick leave by 2.7 billion euros yearly, with no evidence of increased hospitalizations or daily use post-reform.

“At a time when Germany’s healthcare system is overstretched, and health insurers are under financial pressure, this model should serve as a benchmark, not a target for rollback,” said Kouparanis.

The report also emphasizes the role of importers, wholesalers and pharmacies that have invested substantial resources — and created jobs — to build an innovative digital supply chain to ensure nationwide access. Kouparanis emphasized that this chain is now at risk due to the regulatory risks introduced by the proposed amendment.

Regulatory risks in Germany’s cannabis market

The authors believe the Ministry of Health’s proposals are based on unsubstantiated misuse fears.

Wichmann argued against the idea of these risks from pharmaceutically supplied medical cannabis.

“This is especially true when compared to other prescription medications commonly used to treat the same conditions, as the addiction risks for opioids and Z-drugs have already been well established,’ he continued, highlighting the benefits of affordable digital access for medical cannabis therapy on the private market.

“If policymakers continue to stigmatize medical cannabis and restrict telemedicine and shipping pharmacies, they risk pushing vulnerable patients back to medications with more severe side effects as well as unsafe cannabis from unregulated sources, undermining both the wellbeing of individual patients and public health as a whole.”

German cannabis market outlook

North American investors are betting on Germany’s medical cannabis staying power, as seen in recent acquisitions of key players in the country like Sanity Group and Remixian.

“Legal cannabis is here to stay,” said Kouparanis, underscoring market resilience despite the regulatory debates.

Highlighting the sector’s evolution, he noted that despite falling prices, major wholesalers may still be profitable. “But of course, as with all product-touching business models, such as wholesale and pharmacy, margins are decreasing.”

This shift favors scalable digital platforms amid intensifying competition.

As regulatory hurdles loom, Germany’s medical cannabis market proves a potentially lucrative investment frontier for digitized platforms like Bloomwell, provided policymakers embrace data over dogma.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

(TheNewswire)

   

Vancouver, Canada, February 24, 2026 TheNewswire Spartan Metals Corp. (‘Spartan’ or the ‘Company’) (TSX-V: W | OTCQB: SPRMF | FSE: J03) reports that Burton Egger (the ‘Acquiror’) a director of the Company has  acquired 1,400,000 common shares of the Company (the ‘Acquired Shares’) by way of the exercise of 1,400,000 common share purchase warrants at a purchase price of $0.075 per Acquired Share (the ‘Acquisition’).

 

Prior to the completion of the Acquisition, Mr. Egger beneficially owned or exercised control or direction over 7,222,341 common shares, 1,604,166 common share purchase warrants (‘Warrants‘) and 50,000 restricted share units (‘RSU’s‘), representing approximately 18.3% per cent of the issued and outstanding common shares on an undiluted basis and 21.56% on a partially diluted basis. Upon completion of the Acquisition, Mr. Egger beneficially owns or exercises control or direction over 8,622,341 common shares 204,166 Warrants and 50,000 RSU’s, representing approximately 21.7% per cent of the issued and outstanding common shares on an undiluted basis, and 21.56% per cent of the issued and outstanding common shares on a partially diluted basis, assuming that Mr. Egger exercised all of his warrants and RSU’s, and no other holders of convertible securities exercised or converted any of their securities.

 

The Acquired Shares were acquired for investment purposes. Depending on market conditions, the Acquiror may, from time to time, acquire additional securities, exercise convertible securities, dispose of some or all of the existing or additional securities or may continue to hold the securities of the Company.

 

About Spartan Metals Corp.

Spartan Metals is focused on developing critical minerals projects in well-established and stable mining jurisdictions in the Western United States, with an emphasis on building a portfolio of diverse strategic defense minerals such as Tungsten, Rubidium, Antimony, Bismuth, and Arsenic.

 

Spartan’s flagship project is the Eagle Project in eastern Nevada that consists of one of the highest-grade historic tungsten resources in the USA (the past-producing Tungstonia Mine) along with significant under-defined resources consisting of: rubidium; antimony; bismuth; indium; as well as precious and base metals. More information about Spartan Metals can be found at www.SpartanMetals.com  

 

On behalf of the Board of Spartan

‘Brett Marsh’

President, CEO & Director

 

Further Information:

Brett Marsh, M.Sc., MBA, CPG

President, CEO & Director

1-888-535-0325

info@spartanmetals.com

 

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release

 

Copyright (c) 2026 TheNewswire – All rights reserved.

News Provided by TheNewsWire via QuoteMedia

This post appeared first on investingnews.com

Golconda Gold Ltd. (‘Golconda Gold’ or the ‘Company’) (TSX-V: GG; OTCQB: GGGOF) is pleased to announce that it has been included in the TSX Venture 50 list.

TSX Venture 50 is a ranking of the 50 top-performing companies on the TSX Venture Exchange over the last year. Companies are ranked based on three equally-weighted criteria of one-year share price appreciation, market capitalization increase, and Canadian consolidated trading value.

Ravi Sood, Chief Executive Officer of the Company, commented: ‘We are very pleased to see that the years of investment of both capital and human resources in our business are being recognized in our share price. While it has left us capital constrained for long periods of time, our focus on minimizing shareholder dilution is also now being rewarded. Despite Golconda Gold being 5th on the TSX Venture 50 in terms of price appreciation, we closed 2025 with fewer shares outstanding than we started the year with.’

More details on the TSX Venture 50 can be found at: www.tsx.com/Venture50.

About Golconda Gold

Golconda Gold is an un-hedged gold producer and explorer with mining operations and exploration tenements in South Africa and New Mexico. Golconda Gold is a public company and its shares are quoted on the TSX Venture Exchange under the symbol ‘GG’ and the OTCQB under the symbol ‘GGGOF’. Golconda Gold’s management team is comprised of senior mining professionals with extensive experience in managing mining and processing operations and large-scale exploration programmes. Golconda Gold is committed to operating at the highest standards, focused on the safety of its employees, respecting the environment, and contributing to the communities in which it operates.

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information please contact:
Ravi Sood
CEO, Golconda Gold Ltd.
+1 (647) 987-7663
ravi@golcondagold.com
www.golcondagold.com

News Provided by GlobeNewswire via QuoteMedia

This post appeared first on investingnews.com